HeyJaredVardah Gill
- Indexed articles, last 90 days
- 369
- Latest publication
- Oct 1, 2026
- Outlet visibility, for yahoo.com
- Top 1K sites
- Earliest in this view
- Aug 12, 2026
Latest articles
Would You Buy P&G at this Valuation? (opens the original)
Read excerpt
The Procter & Gamble Company (NYSE:PG) is the kind of business investors usually look at when they want stability rather than rapid growth. The company sells products people use every day across beauty, grooming, health care, fabric and home care, and baby, feminine, and family care. Its brands include Tide, Pampers, Gillette, Oral-B, Crest, Dawn, Downy, Pantene, Olay, Vicks, and many others. Fabric & Home Care is P&G’s biggest business, accounting for 35% of fiscal 2026 sales. Baby, Feminine &
Novoâs Pipeline Strategy Takes Another Step Forward (opens the original)
Read excerpt
Novo Nordisk A/S (NYSE:NVO) has signed a drug-discovery and licensing agreement with Orbis Medicines worth up to $1.4 billion to develop oral therapies for cardiometabolic diseases that are traditionally treated with injections. The deal includes upfront and potential development and commercial milestone payments, tiered royalties on future sales, and a strategic investment by Novo in Orbis. The companies did not disclose the size of the upfront payment, investment, or the breakdown of the $1.4
Aurora Innovationâs Road to Profitability Runs Through Fleet Expansion (opens the original)
Read excerpt
Aurora Innovation, Inc. (NASDAQ:AUR) is trying to move from autonomous-truck commercialization toward profitability by rapidly expanding its driverless fleet. CNBC reported on September 22 that Aurora had about 20 driverless trucks operating and planned to reach 200 by the end of 2026. Its autonomous operations are already running on major Texas freight corridors, including I-45 between Houston and Dallas and I-20 between Fort Worth and El Paso. The company’s September 23 investor presentation p
Goldman Sachs Looks to Deepen its Footprint in Credit (opens the original)
Read excerpt
The Goldman Sachs Group, Inc. (NYSE:GS) is reportedly in talks to acquire Palmer Square Capital Management, a credit-focused asset manager overseeing more than $37 billion, according to Bloomberg. The discussions are ongoing and could still fall apart. If completed, the transaction would extend Goldman’s recent push into asset management after its agreed acquisition of NEOS Investments for up to $2.25 billion and its $2 billion acquisition of Innovator earlier this year. The potential deal fits
Why Amgenâs Pipeline Just Got More Interesting (opens the original)
Read excerpt
Amgen Inc. (NASDAQ:AMGN)’s experimental drug dazodalibep met the main goal of a late-stage trial for Sjögren’s disease. After 48 weeks, patients with moderate-to-severe disease activity showed statistically significant and clinically meaningful improvements. Most adverse events were mild to moderate, and only a small number of patients stopped treatment. Sjögren’s affects about 1% of the global population and currently has no approved treatment in the U.S. The result gives Amgen a potential new
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 1K sites
For yahoo.com, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.